Skip to content

Assessment of Neonatal Sequential Organ Failure Assessment nSOFA Score for Predicting Mortality in Neonates with Late Onset Sepsis

Neonatal Sequential Organ Failure Assessment (nSOFA) Score as a Predictor of Mortality in Late-Onset Neonatal Sepsis: One year hospital based Prospective observational study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110200
Enrollment
90
Registered
2026-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A00-B99- Certain infectious and parasitic diseases

Interventions

Intervention1: Nil: Nil

Sponsors

Jawaharlal Nehru Medical College KLE University Belagavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Neonates age greater than 72 hrs and less than or equal to 28 days of life with culture-positive late onset sepsis (LOS) And or Or Neonates aged greater than 72 hours with Culture-negative LOS Culture-negative LOS is defined as CRP level greater than 10 mg per L at the time of evaluation or antibiotic therapy longer than 5 days (or intention to treat longer for late onset sepsis ) or clinical symptoms of sepsis

Exclusion criteria

Exclusion criteria: 1)Presence of antibiotic exposure for more than 48 hours before the LOS (Late Onset Sepsis ) episode evaluation 2)Early-onset sepsis (less than or equal to 72 hr) 3)Major congenital anomalies (major congenital heart disease, central nervous system malformations, gastrointestinal atresias or abdominal wall defects, congenital diaphragmatic hernia or pulmonary hypoplasia, severe renal anomalies, inborn errors of metabolism, multisystem syndromic anomalies and others) 4)Chromosomal abnormalities (Numerical abnormalities: Trisomy 13, Trisomy 18, Trisomy 21, monosomy X (Turner syndrome); Structural abnormalities: (Deletions, duplications, translocations, and ring chromosomes and others.) 5)Congenital infections like TORCH (Toxoplasmosis, Rubella, Cytomegalovirus, Herpes simplex, Syphilis), as well as congenital HIV, Zika virus infection, parvovirus B19 infection, congenital tuberculosis, listeriosis and others 6)Infants with positive blood cultures with organisms that are frequently considered contaminants, including Bacillus species, Corynebacterium species and others

Design outcomes

Primary

MeasureTime frame
In hospital mortality and length of stay in hospital more than seven days for the treatment of late onset sepsisTimepoint: The study will be conducted over a span of one year

Secondary

MeasureTime frame
1)nSOFA score trends over time 2)Individual components of the nSOFA score in neonates who survived & those who did not 3)nSOFA cut off value to predict mortality Timepoint: The study will be conducted over a span of one year

Countries

India

Contacts

Public ContactDr S M Dhaded

Jawaharlal Nehru Medical College, KLE University

drdhadedsm@gmail.com9844232586

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026